Anti‐hepatitis B virus activity and hepatoprotective effect of des(rhamnosyl) verbascoside from Lindernia ruellioides in vitro

Volume: 35, Issue: 8, Pages: 4555 - 4566
Published: Jun 19, 2021
Abstract
Although clinically approved hepatitis B virus (HBV) polymerase inhibitors (lamivudine‐3TC, entecavir, etc.) serve as effective therapeutics, the virus can easily generate resistance to them. Therefore, the treatment of HBV infection remains a public health problem. Numerous studies have shown that natural products have prospective anti‐HBV activity. The purpose of this study was to isolate and extract des(rhamnosyl) verbascoside from Lindernia...
Paper Details
Title
Anti‐hepatitis B virus activity and hepatoprotective effect of des(rhamnosyl) verbascoside from Lindernia ruellioides in vitro
Published Date
Jun 19, 2021
Volume
35
Issue
8
Pages
4555 - 4566
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.